Catalyst Funds Management Pty LTD Boston Scientific Corp Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 2,700 shares of BSX stock, worth $236,493. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,700Holding current value
$236,493% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BSX
# of Institutions
1,533Shares Held
1.19BCall Options Held
7.11MPut Options Held
9.51M-
Vanguard Group Inc Valley Forge, PA131MShares$11.5 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.5 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.31 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$2.87 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $125B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...